At times, Exactech, a medical device company based in Florida, has found itself embroiled in one of the most consequential product liability disputes in the orthopedic implant industry. However, the controversy began with a voluntary recall issued in 2021, which later expanded to cover hundreds of thousands of hip, knee, and ankle implants due to defective packaging that typically permits oxidation of polyethylene components. 

However, this design flaw led to accelerated wear, implant failure, and necessitated revision surgeries in several patients.

What Was Recalled and Why It Matters

Exactech’s recall affected devices such as the Connexion, GXL hip liners, Optetrak knee systems, TKR components, and ankle liners like Vantage, which were manufactured prior to 2004. 

Furthermore, packaging defects, resulting from off-specification packaging or compromised vacuum seals, expose components to oxygen, leading to premature degradation and mechanical failure, such as cracking, loosening, instability, bone degradation, and swelling. However, surgeons were instructed to halt use of the recalled devices, monitor affected patients, and consider revision surgeries when warranted.

What is the Mounting Wave of Litigation & MDL Consolidation?

Since both the patient and plaintiffs began filing the Exactech lawsuit, the litigation has rapidly centralized into a multi-district litigation in the Eastern District of New York, which Judge Nicholas G. Garaufis oversee. While on the state level, Florida courts also consolidated many cases into their own MDL. 

According to the mass tort attorneys from People For Law, by late 2024, approximately 1,770 to 1,800 lawsuits will be active in the federal MDL, with additional filings in state courts, especially in Florida. 

Bellwether Trials and Pretrial Developments

However, to assess and predict outcomes, courts have already selected bellwether cases, for example.

• Tarloff vs Exactech is scheduled for a June 2025 trial, marking the first bellwether in the MDL. 
• Whereas, Larson vs Exactech is slated for August 2025. 
• Furthermore, a third trial, Kramer vs Exactech, is pending selection, and a fourth is under consideration.

While the pretrial discovery timelines have gradually evolved. 

• While the core depositions are initially due by June 2024, they have been extended back to August 29, 2024. 
• While plaintiffs ‘ expert reports are already due around September, they have been shifted to November. 
• Even the defendants’ reports were pushed to January 2025. Rebuttal testimonies are also due in February 2025. 

However, according to separate key developments, it is the court that dismissed exactech lawsuit claims against Exactech’s private equity owner, TPG Inc., finding insufficient control to hold them liable. 

Economic Fallout and Bankruptcy Maneuvers

In October 2024, Exactech had already filed for Chapter 11 bankruptcy in Delaware, citing approximately USD 352 million in debt and litigation-related expenses tied to over 2,600. 

However, this move was aimed at restructuring, resolving various claims, and potentially selling its assets. Although Exactech has sought a deal to protect TPG from liability for a USD 10 million contribution, a strong creditor opposition derailed that plan.

Under a revised proposal, a new ownership structure, potentially involving a trust to manage the unsecured claimants, has been proposed, with estimates suggesting that the claim could exceed USD 1 billion.

What does this mean for Victims and Law Firms?

It is the patient who received recalled implants and has experienced pain, instability, swelling, grinding noises, or required revision surgery who might be eligible for compensation. According to the mass tort attorneys from People For Law, some firms even work with a third-party administrator to facilitate claims. However, individuals may attain significant recovery through mass tort litigation. 

The lawyers are representing individuals nationwide and tracking bellwether timelines, as well as evolving pretrial schedules. 

Others emphasize their readiness to go “toe-to-toe” with powerful defense teams while offering individualised attention.

What are the key takeaways for the Readers?

If you have received an Exactech hip, knee, or ankle implant since 2004, consult our surgeons for signs of recall and failure. Monitor symptoms such as joint pain, instability, swelling, and mechanical noises. 

Please contact our mass tort attorney, experienced in product liability; the MDL is active, and deadlines may approach rapidly. Stay well-informed about Bellwether case outcomes, as they often influence settlement values. However, bankruptcy developments always matter, as recovery may hinge on whether TPG remains liable and what structure the bankruptcy outcome takes.

Bottom Line

The Exactech mass tort litigation clearly underscores the higher stakes associated with defective medical devices. Even thousands of patients have already been affected by substandard packaging that precipitated premature implant failure.  

As MDL proceedings, Bellwether trials, and bankruptcy court processes continue to unfold, skilled mass tort attorneys are well-positioned to guide affected individuals toward fair compensation.

If you would like help crafting a more attorney-focused guide, for example, explaining the intake, filing strategies, and how to join the MDL, just stay in touch. If you’d like help crafting a more attorney‑focused guide—for example, explaining intake, filing strategies, or how to join the MDL—just say the word!